•
Mar 28, 2020

Thermo Fisher Q1 2020 Earnings Report

Reported financial results for the first quarter ended March 28, 2020.

Key Takeaways

Thermo Fisher Scientific's first quarter revenue increased by 2% to $6.23 billion. GAAP diluted EPS decreased by 2% to $1.97, while adjusted EPS increased by 5% to $2.94.

First quarter revenue increased 2% to $6.23 billion.

First quarter GAAP diluted earnings per share (EPS) decreased 2% to $1.97.

First quarter adjusted EPS increased 5% to $2.94.

Announced agreement to acquire QIAGEN N.V. for $11.5 billion, expanding specialty diagnostics portfolio and enhancing life sciences offering.

Total Revenue
$6.23B
Previous year: $6.13B
+1.7%
EPS
$2.94
Previous year: $2.81
+4.6%
Adjusted Operating Margin
22.1%
Previous year: 22.4%
-1.3%
Gross Profit
$2.87B
Previous year: $2.83B
+1.2%
Cash and Equivalents
$2.98B
Previous year: $1.11B
+169.5%
Free Cash Flow
$107M
Previous year: $448M
-76.1%
Total Assets
$58.7B
Previous year: $55.6B
+5.6%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher announced on April 6, 2020, that it withdrew its 2020 annual guidance due to the evolving COVID-19 pandemic and related customer impact.

Revenue & Expenses

Visualization of income flow from segment revenue to net income